Introduction
Infection with human immunodeficiency virus (HIV) results in profound dysfunction of both cell-mediated and humoral immunity predisposing patients to severe opportunistic infection and Kaposi's sarcoma. Patients with the acquired immunodeficiency syndrome often develop multi-system organ damage including widespread involvement of the gastro-intestinal tract. The development of abdominal symptoms often prompts serum amylase determination.
Patients with unexplained hyperamylasaemia are often subjected to multiple diagnostic tests or even laparotomy. Macroamylasaemia is a frequently overlooked cause of hyperamylasaemia and must be excluded to avoid making erroneous diagnoses. We report the first case of macroamylasaemia in association with the acquired immunodeficiency syndrome.
Case report
A 23 year old promiscuous heterosexual male was hospitalised after two months of fever, dyspnoea, and chest pain. Seven months previously oral candidiasis was noted and four months before admission a routine blood count revealed a teucocyte count of 1.9 x 109/1 and platelet count of 1 Macroamylasaemia has been found to occur in association with a variety of diseases including diabetes mellitus, cancer, alcoholism, systemic lupus erythematosus, and liver disease and occurs with greater frequency in patients with disturbed humoral immunity and autoimmune diseases. In the latter setting, macroamylasaemia may reflect an aberrant state ofimmunoglobulin production.' It has also been described in malabsorption syndromes and other inflammatory diseases of the gut suggesting increased absorption of luminal antigen from altered gut permeability. 4 The significance of macroamylasaemia in apparently healthy persons is unknown and it remains unclear whether this represents an early marker of disease. However, the correlation in some patients between macroamylase level and fluctuations in activity of underlying disease suggests a direct relationship between the two conditions.5
The acquired immunodeficiency syndrome (AIDS) is characterized by a profound alteration in both the cellular and humoral arms ofthe immune system.6 The polyclonal B cell activation, increased spontaneous immunoglobulin secretion, and elevated levels of serum immunoglobulins and circulating immune complexes in AIDS may predispose these patients to macroamylase formation. In addition, the enteropathy ofAIDS may result in the presentation of an increased antigenic load through the diseased mucosa to the enteric immune system similar to that described in patients with other malabsorption syndromes and macroamylasaemia. 7 This patient has type I macroamylasaemia characterized by an increased serum amylase and a low urinary amylase. An Macroamylasaemia is a benign condition that requires no special treatment. Gastrointestinal symptoms commonly occur in AIDS and often prompt serum amylase determination. Macroamylasaemia should be excluded in patients with AIDS and hyperamylasaemia to avoid an invasive and prolonged workup.
